Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus

Journal of Immunology

Volumn 165, Issue 6, 2000, Pages 3436-3443

  Liang, B ^a   Kashgarian, M J ^a   Sharpe, A H ^a   Mamula, M J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; LIGAND; SMALL NUCLEAR RIBONUCLEOPROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; IMMUNOGLOBULIN DEPOSITION; LYMPHOCYTE ACTIVATION; MEMORY CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0034665384     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.6.3436     Document Type: Article

References (43)

1. The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice
2. MRL lpr/lpr disease: Theories meet Fas
3. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus
4. Antibodies to DNA
5. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice
6. Treatment of autoimmune MRL/lpr mice with monoclonal antibody to Thy-1. 2: A single injection has sustained effects on lymphoproliferation and renal disease
7. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice
8. Long-term anti-CD4 treatment of MRL/lpr mice ameliorates immunopathology and lymphoproliferation but fails to suppress rheumatoid factor production
9. Reduction of mortality and lymphadenopathy in MRL-lpr/lpr mice treated with nonmitogenic anti-CD3 monoclonal antibody
10. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506
11. CS-A therapy in MRL-lpr/lpr mice: Amelioration of immunopathology despite autoantibody production
12. + T cells
13. Treatment of murine lupus with CTLA4Ig
14. Differential effects of anti-B7.1 and anti-B7.2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
15. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation
16. B7.1 and B7.2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
17. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule
18. B7 costimulation in the development of lupus: Autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-B7.1/B7.2 blocking antibodies
19. Uncovering of functional alternative CTLA4 counter-receptor in B7-deficient mice
20. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation
21. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response
22. + T cells
23. Role of costimulators in T cell differentiation
24. The cellular basis for the Ig restriction in murine experimental autoimmune thyroiditis
25. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis
26. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
27. B7h, a novel costimulatory homologue of B7.1 and B7.2, is induced by TNFα
28. Selection of the T cell receptor repertoire in lpr mice
29. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis
30. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus
31. LE or not LE-that is the question: An unsuccessful attempt to separate lymphocytic infiltration from the spectrum of discoid lupus erythematosus
32. + T cells use both CD95-dependent and CD95-independent cytolytic mechanisms
33. Stimulation of IFN-γ, TNF-α, and TNF-β secretion in IL-2-activated T cells: Costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules
34. + T cell clones secrete the Th1 pattern of cytokines
35. The changing preference of T and B cells for partners as T-dependent antibody responses develop
36. + T cells
37. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogenic target cells
38. + T cell-mediated cytotoxicity
39. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts
40. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes
41. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
42. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: A tale of smart bombs and the infantry
43. The central and multiple roles of B cells in lupus pathogenesis